Editorial
World J Virol
10(2):30-33.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.30
Abstract (971)
|
Core Tip (965)
|
Full Article (HTML) (2203)
|
Figures (1-4) (1009)
|
Full Article (PDF)-1129K (342)
|
Audio-540K (12)
|
Peer-Review Report-149K (164)
|
Answering Reviewers-64K (144)
|
Received: 01/14/2021
|
Revised: 01/30/2021
|
Accepted: 02/05/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (10004)
|
Similar Articles (1)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
World J Virol
10(2):34-52.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.34
Abstract (1622)
|
Core Tip (1089)
|
Full Article (HTML) (12351)
|
Tables (1-3) (521)
|
Full Article (PDF)-950K (1048)
|
Audio-1256K (33)
|
Peer-Review Report-242K (305)
|
Answering Reviewers-119K (313)
|
Received: 12/29/2020
|
Revised: 01/23/2021
|
Accepted: 03/12/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (16)
|
Total Visits (22967)
|
Similar Articles (714)
|
Timeline of Article Publication (1)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review

World J Virol
10(2):53-61.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.53
Abstract (955)
|
Core Tip (971)
|
Full Article (HTML) (2950)
|
Tables (1-3) (523)
|
Full Article (PDF)-837K (291)
|
Audio-1070K (31)
|
Peer-Review Report-217K (172)
|
Answering Reviewers-69K (173)
|
Received: 12/12/2020
|
Revised: 01/28/2021
|
Accepted: 03/08/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (9932)
|
Similar Articles (702)
|
Timeline of Article Publication (9)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza

World J Virol
10(2):62-68.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.62
Abstract (1009)
|
Core Tip (966)
|
Full Article (HTML) (3162)
|
Figures (1-2) (581)
|
Tables (1-3) (506)
|
Full Article (PDF)-4630K (370)
|
Audio-444K (9)
|
Peer-Review Report-202K (188)
|
Answering Reviewers-117K (209)
|
Received: 12/18/2020
|
Revised: 01/16/2021
|
Accepted: 02/20/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (11520)
|
Similar Articles (806)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Epidemiological characterization and geographic distribution of human immunodeficiency virus/acquired immunodeficiency syndrome infection in North African countries

World J Virol
10(2):69-85.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.69
Abstract (1057)
|
Core Tip (959)
|
Article Highlights (1033)
|
Full Article (HTML) (3821)
|
Figures (1-8) (564)
|
Tables (1-1) (547)
|
Full Article (PDF)-10779K (321)
|
Audio-581K (24)
|
Peer-Review Report-162K (210)
|
Answering Reviewers-206K (208)
|
Received: 11/04/2020
|
Revised: 12/22/2020
|
Accepted: 01/08/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (13636)
|
Similar Articles (1)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open